Table 1.

Diabetic medications taken during the study. DFU study subjects listed by number with their prestudy medications for glycemic control. Healed indicates subjects with healed study DFU wounds at the completion of the twelve-week observation period. TIDM indicates study subject with type I DM; all other subjects are with type II DM.

Patient number	Prior therapy	DFU status
1	Tradjenta (linagliptin)	Nonhealing
2	Lantus/Humalog Insulin	Nonhealing
3	Glimepiride	Nonhealing
4	Glipizide; Metformin	Healed
5	Lantus/Humalog Insulin	Nonhealing
6	Humalog/Humulin N Insulin	Nonhealing
7	Humalog/Humulin N Insulin (TIDM)	Nonhealing
8	Humulin 70/30 Insulin	Nonhealing
9	Glipizide/Novolog and Lantus Insulin	Healed
10	Glimepiride/Victoza and Invokana Insulin	Nonhealing
11	Glyburide/Lantus and Humalog Insulin; Metformin	Healed
12	Glimepiride; Metformin	Nonhealing
13	Humulin 70/30 Insulin	Nonhealing
14	Lantus Insulin	Nonhealing
15	Novolog and Lantus Insulin	Nonhealing
16	Lantus and Novolog Insulin, Metformin	Nonhealing
17	Novolin N and Novolin R Insulin; Actos	Nonhealing
18	Glipizide, Metformin, Januvia	Nonhealing